SKA3 Antikörper (AA 1-412)
Kurzübersicht für SKA3 Antikörper (AA 1-412) (ABIN7825858)
Target
Alle SKA3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-412
-
Verwendungszweck
- Anti-C13orf3/SKA3 Antibody
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins
-
Produktmerkmale
- Anti-C13orf3/SKA3 Antibody (ABIN7825858). Tested in WB, IHC, ELISA applications. This antibody reacts with Human. This is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human C13orf3/SKA3 recombinant protein (Position: M1-N412). Human C13orf3/SKA3 shares 61.6% and 61.8% amino acid (aa) sequence identity with mouse and rat C13orf3/SKA3, respectively.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western blot, 0.25-0.5 μg/mL, Human
Immunohistochemistry, 2-5 μg/mL, Human
ELISA, 0.1-0.5 μg/mL
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Konzentration
- 500 μg/mL
-
Buffer
- Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.
-
-
- SKA3 (Spindle and Kinetochore Associated Complex Subunit 3 (SKA3))
-
Andere Bezeichnung
- SKA3
-
Hintergrund
- This gene encodes a component of the spindle and kinetochore-associated protein complex that regulates microtubule attachment to the kinetochores during mitosis. The encoded protein localizes to the outer kinetechore and may be required for normal chromosome segregation and cell division. Alternative splicing results in multiple transcript variants.
-
Molekulargewicht
- 51 kDa
-
Gen-ID
- 221150
Target
-